Improving bone healing using modified RNA
Use of Chemically Modified RNA to Enhance Bone Healing
This study is looking at how a special type of RNA can help your body heal big bone injuries better by teaching it to make its own healing proteins, which could mean less pain and a quicker recovery for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10673114 on NIH RePORTER |
What this research studies
This research investigates how chemically modified RNA can enhance the healing of large bone defects caused by injuries, tumors, or congenital deformities. The approach focuses on delivering messenger RNA (mRNA) that instructs the body to produce its own bone healing proteins, rather than relying on traditional methods that often fail due to poor delivery of these proteins. By using mRNA, the goal is to promote more effective and efficient bone regeneration, potentially reducing the need for invasive procedures. Patients may benefit from a less painful and more successful healing process.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with large segmental bone defects due to injury, tumor removal, or congenital deformities.
Not a fit: Patients with minor bone injuries or those whose conditions do not involve significant bone loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healing outcomes for patients with significant bone injuries or congenital defects.
How similar studies have performed: Previous research has shown promise in using gene therapy and mRNA delivery for bone healing, indicating a potential for success with this novel approach.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Evans, Christopher Howard — Mayo Clinic Rochester
- Study coordinator: Evans, Christopher Howard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.